New Delhi, May 7 (IANS) Certain drugs used to treat type 2 diabetes can also be used to treat prostate cancer, according to a study.
Researchers from the Medical University of Vienna in Austria identified similarities in the mechanisms of diabetes and cancer.
They showed that the protein PPARγ (peroxisome proliferator-activated receptor gamma) — central to the regulation of metabolic processes — can also influence the growth of prostate cancer cells.
But PPARγ is already known to be a target of certain drugs including so-called thiazolidinediones such as pioglitazone, which are used to treat type 2 diabetes.
The findings “showed that the diabetes drug pioglitazone influences the activity of PPARγ and thus inhibits the growth behaviour and metabolism of tumour cells. Furthermore, initial results revealed that prostate cancer patients with diabetes who were treated with PPARγ agonists had not relapsed at the time of data collection,” explained Emine Atas from the Department of Biomedical Imaging and Image-guided Therapy at the varsity.
The study, published in the journal Molecular Cancer, indicates that such drugs could slow down growth of prostate cancer cells, representing a promising approach for the treatment of prostate cancer.
The researchers examined cell cultures and tissue samples from patient cohorts. They analysed how different activation states of the protein affect the cells.
Prostate cancer occurs when abnormal cells in the prostate gland grow out of control. Despite enormous medical advances in recent years, prostate cancer is the most common cancer in men, with an estimated 1.4 million diagnoses and 375,000 deaths worldwide in 2020.
The currently available treatment methods range from surgery and radiotherapy to medication. The identification of previously unknown molecular mechanisms could help to develop targeted therapies.
PPARγ, as a potential regulator of tumour growth, is a promising option that will now be investigated in further studies, said the researchers.
–IANS
rvt/
Disclaimer
The information contained in this website is for general information purposes only. The information is provided by BhaskarLive.in and while we endeavour to keep the information up to date and correct, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.
In no event will we be liable for any loss or damage including without limitation, indirect or consequential loss or damage, or any loss or damage whatsoever arising from loss of data or profits arising out of, or in connection with, the use of this website.
Through this website you are able to link to other websites which are not under the control of BhaskarLive.in We have no control over the nature, content and availability of those sites. The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.
Every effort is made to keep the website up and running smoothly. However, BhaskarLive.in takes no responsibility for, and will not be liable for, the website being temporarily unavailable due to technical issues beyond our control.
For any legal details or query please visit original source link given with news or click on Go to Source.
Our translation service aims to offer the most accurate translation possible and we rarely experience any issues with news post. However, as the translation is carried out by third part tool there is a possibility for error to cause the occasional inaccuracy. We therefore require you to accept this disclaimer before confirming any translation news with us.
If you are not willing to accept this disclaimer then we recommend reading news post in its original language.
